{"nbformat":4,"nbformat_minor":0,"metadata":{"kernelspec":{"display_name":"Python 3","language":"python","name":"python3"},"language_info":{"codemirror_mode":{"name":"ipython","version":3},"file_extension":".py","mimetype":"text/x-python","name":"python","nbconvert_exporter":"python","pygments_lexer":"ipython3","version":"3.8.5"},"colab":{"name":"Specialite_bibliovid.ipynb","provenance":[],"collapsed_sections":[]}},"cells":[{"cell_type":"markdown","metadata":{"id":"ZIbXTbO-vOsd"},"source":["# Recupération des données bibliovid"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"dJY_qpwmDR3b","executionInfo":{"status":"ok","timestamp":1609592662124,"user_tz":-60,"elapsed":21889,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"5c3ff90f-eba5-4af9-abe3-d5359e8c5eb3"},"source":["from google.colab import drive\n","import os \n","drive.mount('drive')\n","os.chdir(\"drive/My Drive/Colab Notebooks/TAL/\")\n","!ls"],"execution_count":null,"outputs":[{"output_type":"stream","text":["Mounted at drive\n"," biblio.csv\t\t\t      nbre_par_spe.png\n"," bibliovid.json\t\t\t      __pycache__\n"," biobert_v1.1_pubmed.tar.gz\t      Specialite_bibliovid_2.ipynb\n","'Copie de Biobert_categories.ipynb'   Specialite_bibliovid.ipynb\n"," models\t\t\t\t      ULMfit.ipynb\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"bpPD11LVvOsl"},"source":["# récupération des données\n","import json\n","with open('bibliovid.json') as json_data:\n","    data_dict = json.load(json_data)"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"scrolled":true,"id":"Gyg6-c1svOsn","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609592662618,"user_tz":-60,"elapsed":20206,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"a6e44c96-fa3b-4e53-9cfa-c10c14378871"},"source":["print(\"Nombres d'article:\",len(data_dict))\n","print(\"Avec ces informations pour chacun:\")\n","for i in data_dict:\n","    for cle, val in i.items():\n","        print(cle)\n","    break"],"execution_count":null,"outputs":[{"output_type":"stream","text":["Nombres d'article: 682\n","Avec ces informations pour chacun:\n","id\n","slug\n","title\n","has_other_authors\n","impact_factor\n","goals_plain\n","verbose_date\n","authors\n","document_link\n","specialties\n","category\n","journal\n","link\n","results\n","synthesis\n","strength_of_evidence_details\n","goals\n","methods\n","pubmed_id\n","doi\n","abstract\n","topics\n","author_list\n","publication_date\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"6-badmRpvOso","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609576110429,"user_tz":-60,"elapsed":827,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"a103095c-f371-4678-f3e6-22676a939adf"},"source":["print('Un exemple d\\'articles:')\n","print(data_dict[1])"],"execution_count":null,"outputs":[{"output_type":"stream","text":["Un exemple d'articles:\n","{'id': 756, 'slug': 'optimal-covid-19-epidemic-control-until-vaccine-deployment', 'title': 'Optimal COVID-19 epidemic control until vaccine deployment', 'has_other_authors': True, 'impact_factor': {'id': 4, 'name': 'Indéterminé', 'posts_count': 96, 'color': 'gray', 'order': 4}, 'goals_plain': 'L\\'objectif de cette étude est de déterminer des stratégies permettant le contrôle d\\'une épidémie limitant au maximum le nombre de morts dûs à cette épidémie, ainsi que le coût associé à cette politique de contrôle. En particulier, l\\'article prend en compte l\\'augmentation de la mortalité associée à une saturation du système de santé. Différentes stratégies \"réalistes\" sont également considérées, comme une politique de contrôle mise à jour à intervalles réguliers, une politique de contrôle constante, ou une alternance entre période de contrôle maximal (type confinement) et minimal.', 'verbose_date': '22.07.2020', 'authors': 'Djidjou-Demasse R', 'document_link': 'https://www.medrxiv.org/content/10.1101/2020.04.02.20049189v3.full.pdf', 'specialties': [{'id': 12, 'name': 'Infectiologie'}], 'category': {'id': 8, 'name': 'Modélisation', 'icon': 'icon-all'}, 'journal': {'id': 85, 'name': 'Pre-prints'}, 'link': 'https://www.medrxiv.org/content/10.1101/2020.04.02.20049189v3.full.pdf', 'results': \"Les auteurs montrent qu'une stratégie d’atténuation de l'épidémie jusqu'à l'obtention d'un vaccin existe, et que de telles stratégies permettent de diminuer grandement le nombre de morts sur cette période. Il est a noter que la stratégie optimale (en tout cas avec les paramètres choisis) semble être de conserver le nombre d'infectés sévères à un niveau très faible (un centième de la capacité des unités de soins intensifs), puis de relâcher le confinement juste avant le déploiement du vaccin. Les auteurs montrent également que ces résultats sont relativement stables. Ainsi, le fait de mettre à jour la stratégie de confinement à intervalles réguliers en fonction des données de la période précédente est suffisant pour obtenir un contrôle efficace du nombre de morts liés à la pandémie.\", 'synthesis': \"Cet article détermine les méthodes de contrôle optimales d'une épidémie sur une période de temps fixée (en attente d'un vaccin). Le but est de contrôler l'épidémie en minimisant le nombre de décès causés, directement et indirectement, par la saturation du système de santé ainsi que le coût associé à la stratégie de contrôle.\", 'strength_of_evidence_details': \"C'est un résultat très intéressant d'optimisation, les auteurs tiennent compte de la saturation du système médical en cas d'épidémie et du nombre de décès qui y sont liés.  Le modèle utilisé par les auteurs est assez complexe, avec un grand nombre de paramètres. Il est à noter qu'ici le temps T auquel le vaccin sera déployé est considéré comme connu, ce qui a un impact non-négligeable sur la solution optimale (le confinement est relâché un certain temps avant T, car les nouveaux contaminés mourront après T. Il aurait été également intéressant d'étudier l'effet du paramètre mesurant le coût relatif du confinement par rapport au nombre de morts.\", 'goals': 'L\\'objectif de cette étude est de déterminer des stratégies permettant le contrôle d\\'une épidémie limitant au maximum le nombre de morts dûs à cette épidémie, ainsi que le coût associé à cette politique de contrôle. En particulier, l\\'article prend en compte l\\'augmentation de la mortalité associée à une saturation du système de santé. Différentes stratégies \"réalistes\" sont également considérées, comme une politique de contrôle mise à jour à intervalles réguliers, une politique de contrôle constante, ou une alternance entre période de contrôle maximal (type confinement) et minimal.', 'methods': \"Les auteurs considèrent un modèle relativement complexe type SEAIR avec différentiation entre forme sévère et modérée. Les individus peuvent être Susceptibles (S) d'être contaminés, puis deviennent Exposés (E) en cas de contamination. Après un temps de latence, ces individus deviennent porteurs Asymptomatiques (A), période pendant laquelle ils sont contaminants, puis Infectés (I) et symptomatiques, et enfin Rétablis (R). Une fraction des individus contaminés développent une forme sévère de la maladie. Si ces individus sont suffisamment peu nombreux pour être tous traités, leur taux de mortalité reste assez bas. En revanche, si celui-ci est trop haut, leur taux de mortalité augmente beaucoup, ainsi que celui de tous les individus malades pour d'autres raisons, dû à la saturation du système de santé. Les auteurs utilisent des méthodes classiques d'équations différentielles et d'optimisation pour déterminer la stratégie de contrôle de l'épidémie (par le taux d'infection) optimale, qui minimise à la fois le nombre total de morts, la durée et l'intensité de la politique de contrôle. Grâce à des méthodes d'analyse numérique, ils peuvent simuler la valeur de ces optima et l'évolution de l'épidémie sous ces stratégies optimales.\", 'topics': ['Modélisation', 'Infectiologie'], 'author_list': [{'id': 702, 'name': 'Djidjou-Demasse R'}], 'publication_date': '2020-07-22'}\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"MSrA9w5rvOso","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609576112181,"user_tz":-60,"elapsed":1387,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"1e422258-4201-48ac-963f-4cce09c0162c"},"source":["print('Comment sont représentés les spécialités')\n","print(data_dict[28]['specialties'])"],"execution_count":null,"outputs":[{"output_type":"stream","text":["Comment sont représentés les spécialités\n","[{'id': 21, 'name': 'Confinement/Déconfinement'}]\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"4BA71_igvOsp","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609576113481,"user_tz":-60,"elapsed":890,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"bea03efb-0da6-482a-8cbd-ac546946e012"},"source":["print('Un exemple d\\'abstract')\n","print(data_dict[0]['abstract'])"],"execution_count":null,"outputs":[{"output_type":"stream","text":["Un exemple d'abstract\n","Obesity is a risk factor for pneumonia and acute respiratory distress syndrome.\n","To determine whether obesity is associated with intubation or death, inflammation, cardiac injury, or fibrinolysis in coronavirus disease 2019 (COVID-19).\n","Retrospective cohort study.\n","A quaternary academic medical center and community hospital in New York City.\n","2466 adults hospitalized with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection over a 45-day period with at least 47 days of in-hospital observation.\n","Body mass index (BMI), admission biomarkers of inflammation (C-reactive protein [CRP] level and erythrocyte sedimentation rate [ESR]), cardiac injury (troponin level), and fibrinolysis (D-dimer level). The primary end point was a composite of intubation or death in time-to-event analysis.\n","Over a median hospital length of stay of 7 days (interquartile range, 3 to 14 days), 533 patients (22%) were intubated, 627 (25%) died, and 59 (2%) remained hospitalized. Compared with overweight patients, patients with obesity had higher risk for intubation or death, with the highest risk among those with class 3 obesity (hazard ratio, 1.6 [95% CI, 1.1 to 2.1]). This association was primarily observed among patients younger than 65 years and not in older patients (\n","Body mass index was missing for 28% of patients. The primary analyses were conducted with multiple imputation for missing BMI. Upper bounding factor analysis suggested that the results are robust to possible selection bias.\n","Obesity is associated with increased risk for intubation or death from COVID-19 in adults younger than 65 years, but not in adults aged 65 years or older.\n","National Institutes of Health.\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"8w-9E82hvOsp"},"source":["specialties = {} # dictionnaire id -> specialité\n","nb_per_spe = {}  # nombres d'articles par spécialité"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"RbQo1Ix7vOsp"},"source":["ind_spe = 0\n","for article in data_dict:\n","    for spe in article['specialties']:\n","        if spe['name'] not in specialties.keys():\n","            specialties[spe['name']] = ind_spe\n","            nb_per_spe[spe['name']] = 0\n","            ind_spe += 1\n","        nb_per_spe[spe['name']] += 1"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"CJFDP34UvOsq","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609592672376,"user_tz":-60,"elapsed":342,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"2cf254a6-3249-452e-cae2-f865f2a68f4b"},"source":["specialties"],"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["{'Anesthésie-Réanimation': 0,\n"," 'Cardiologie et maladies métaboliques': 10,\n"," 'Confinement/Déconfinement': 5,\n"," 'Dermatologie': 15,\n"," 'Gynécologie Obstétrique': 8,\n"," 'Gériatrie': 9,\n"," 'Hygiène': 11,\n"," 'Hématologie': 16,\n"," 'Hépato-gastro-entérologie': 12,\n"," 'Immunité': 3,\n"," 'Infectiologie': 1,\n"," 'Neurologie': 13,\n"," 'Néphrologie': 18,\n"," 'Pneumologie': 7,\n"," 'Psychiatrie': 17,\n"," 'Pédiatrie': 6,\n"," 'Radiologie': 14,\n"," 'Transversale': 2,\n"," 'Virologie': 4}"]},"metadata":{"tags":[]},"execution_count":7}]},{"cell_type":"code","metadata":{"id":"eQTThqDxvOsq"},"source":["LABELS = list(specialties.keys())"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"U1CnLhOrvOsq","colab":{"base_uri":"https://localhost:8080/","height":729},"executionInfo":{"status":"ok","timestamp":1609593517527,"user_tz":-60,"elapsed":1227,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"b7de4541-577c-48e2-a22c-f0fede8c850f"},"source":["import matplotlib.pyplot as plt\n","import numpy as np\n","fig = plt.figure(figsize=(15,10))\n","plt.bar(np.arange(19), nb_per_spe.values())\n","plt.title('Nombre d\\'articles par spécialité',size='xx-large')\n","plt.ylabel('Nombre d\\'article',size='x-large')\n","plt.xticks(np.arange(19), nb_per_spe.keys(), rotation='vertical',size='xx-large')\n","plt.tight_layout()\n","fig.savefig('nbre_par_spe.png')\n","plt.show()"],"execution_count":null,"outputs":[{"output_type":"display_data","data":{"image/png":"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\n","text/plain":["<Figure size 1080x720 with 1 Axes>"]},"metadata":{"tags":[],"needs_background":"light"}}]},{"cell_type":"markdown","metadata":{"id":"H4Y0KOvMvOsr"},"source":["On remarque que certaines spécialités sont très peu représentés (Dermatologie, Gériatrie, Néphrologie), ce qui risque de poser problèmes pour des modèles entrainés depuis 0.\n","\n","Au contraire, nous avons beaucoup d'exemples pour la spécialité \"Transversale\", et ce n'est sûrement pas très pertinent car cette spécialité va finalement en englober plusieurs et cela risque de \"brouiller\" nos classifieurs. On pourrait par exemple mettre la spécialité Transversale si on a déjà prédit 2 spécialité pour l'article."]},{"cell_type":"markdown","metadata":{"id":"nzO2P86cvOsr"},"source":["## Préparation des données"]},{"cell_type":"markdown","metadata":{"id":"uDuBli4-vOsr"},"source":["On va récupérer les données qui nous intéresse."]},{"cell_type":"code","metadata":{"id":"avWhnkn3vOsr"},"source":["import utils\n","texts, Y = utils.get_data(data_dict, get_abstract = False)"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"ZTUpxJr5vOsr","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609583471360,"user_tz":-60,"elapsed":1077,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"69d857f1-8b33-4264-b126-2de19bd62f7a"},"source":["print(\"y shape:\",Y.shape)"],"execution_count":null,"outputs":[{"output_type":"stream","text":["y shape: (682, 19)\n"],"name":"stdout"}]},{"cell_type":"markdown","metadata":{"id":"UPTNT7WLvOss"},"source":["Sur les 682 articles que l'on a, on en a 207 qui n'ont pas d'abstract. On va tenter dans un premier temps de prédire la classe seulement avec le titre afin que toutes les données fassent à peu près la même longueur.\n","\n","Nous allons utiliser les représentations CountVectorizer et TfidVectorizer."]},{"cell_type":"code","metadata":{"id":"oOqp-h6SvOss","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609583472908,"user_tz":-60,"elapsed":1466,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"17f03099-fe2b-4c23-bab5-51bb5fe75ef9"},"source":["from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer\n","vect = CountVectorizer(stop_words=\"english\", max_features=2000, min_df=1)  #max_df\n","vect.fit(texts)\n","vect2 = TfidfVectorizer(stop_words=\"english\", max_features=2000, min_df=1)  #max_df\n","vect2.fit(texts)"],"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["TfidfVectorizer(analyzer='word', binary=False, decode_error='strict',\n","                dtype=<class 'numpy.float64'>, encoding='utf-8',\n","                input='content', lowercase=True, max_df=1.0, max_features=2000,\n","                min_df=1, ngram_range=(1, 1), norm='l2', preprocessor=None,\n","                smooth_idf=True, stop_words='english', strip_accents=None,\n","                sublinear_tf=False, token_pattern='(?u)\\\\b\\\\w\\\\w+\\\\b',\n","                tokenizer=None, use_idf=True, vocabulary=None)"]},"metadata":{"tags":[]},"execution_count":122}]},{"cell_type":"code","metadata":{"id":"QvgXW2-4vOst","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609583474525,"user_tz":-60,"elapsed":1172,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"7803e3ae-d83e-4ada-930f-4d894144fafe"},"source":["print(\"TfidVectorizer\")\n","print(\"Vocabulary size: {}\".format(len(vect2.vocabulary_)))\n","print(\"Vocabulary content:\\n {}\".format(vect2.vocabulary_))"],"execution_count":null,"outputs":[{"output_type":"stream","text":["TfidVectorizer\n","Vocabulary size: 1792\n","Vocabulary content:\n"," {'body': 220, 'mass': 978, 'index': 809, 'risk': 1411, 'intubation': 868, 'death': 420, 'sars': 1429, 'cov': 391, 'infection': 821, 'retrospective': 1399, 'cohort': 307, 'study': 1566, 'optimal': 1120, 'covid': 393, '19': 21, 'epidemic': 559, 'control': 359, 'vaccine': 1725, 'deployment': 439, 'contact': 348, 'rate': 1319, 'equilibrium': 565, 'view': 1750, 'hydroxychloroquine': 744, 'treatment': 1673, 'prophylaxis': 1278, 'non': 1092, 'human': 739, 'primates': 1254, 'infectivity': 824, 'profile': 1266, 'correction': 378, 'mrna': 1039, 'preliminary': 1241, 'report': 1376, 'pathophysiology': 1155, 'transmission': 1665, 'diagnosis': 463, 'coronavirus': 376, 'disease': 483, '2019': 25, 'review': 1404, 'introductions': 866, 'early': 520, 'spread': 1529, 'france': 671, '24': 32, 'january': 888, '23': 31, 'march': 972, '2020': 27, 'opensafely': 1118, 'factors': 623, 'associated': 178, '17': 20, 'million': 1014, 'patients': 1157, 'modelling': 1024, 'designing': 447, 'multi': 1041, 'layered': 912, 'surveillance': 1584, 'approach': 156, 'detect': 448, 'potential': 1221, 'resurgence': 1397, 'estimating': 573, 'overdispersion': 1132, 'using': 1718, 'outbreak': 1127, 'sizes': 1506, 'outside': 1131, 'china': 282, 'expected': 597, 'impact': 789, 'reopening': 1374, 'schools': 1439, 'lockdown': 941, 'île': 1791, 'safely': 1425, 'reopen': 1373, 'colleges': 314, 'universities': 1710, 'experiences': 600, 'taiwan': 1607, 'estimation': 574, 'fatality': 631, 'real': 1328, 'time': 1641, 'antibody': 142, 'screening': 1445, 'blood': 219, 'donors': 502, 'multisystem': 1047, 'inflammatory': 827, 'syndrome': 1600, 'children': 281, 'new': 1084, 'york': 1786, 'state': 1541, 'adolescents': 87, 'convergent': 368, 'responses': 1392, 'convalescent': 366, 'individuals': 815, 'outcomes': 1130, '737': 55, 'treated': 1671, 'azithromycin': 192, 'regimens': 1355, 'marseille': 975, 'analysis': 126, 'differences': 469, 'shedding': 1483, 'duration': 513, 'sputum': 1531, 'nasopharyngeal': 1057, 'swab': 1593, 'specimens': 1526, 'adult': 89, 'inpatients': 842, 'inhalational': 833, 'volatile': 1760, 'based': 195, 'sedation': 1453, 'pneumonia': 1194, 'ards': 160, 'immunity': 776, 'social': 1514, 'distancing': 490, 'sir': 1504, 'model': 1022, 'key': 896, 'questions': 1311, 'exit': 594, 'strategies': 1557, 'dynamics': 516, 'measures': 986, 'driven': 509, 'network': 1075, 'structure': 1564, 'summer': 1571, 'vacation': 1723, 'effects': 528, 'metropolitan': 1008, 'people': 1163, 'going': 692, 'provinces': 1291, 'practical': 1225, 'considerations': 346, 'measuring': 987, 'effective': 526, 'reproductive': 1378, 'number': 1101, 'rt': 1421, 'characterization': 274, 'response': 1391, 'severe': 1479, 'illness': 770, 'determinants': 453, 'severity': 1480, 'cancer': 235, 'household': 737, 'test': 1619, 'sensitivity': 1458, 'secondary': 1449, 'frequency': 673, 'turnaround': 1686, 'dexamethasone': 459, 'clinical': 293, 'presentation': 1244, 'pregnant': 1240, 'women': 1776, 'systematic': 1602, 'meta': 1004, 'posterior': 1216, 'oropharyngeal': 1125, 'saliva': 1427, 'detection': 451, 'national': 1058, 'french': 672, 'survey': 1585, 'symptoms': 1598, 'aged': 99, '70': 52, 'association': 179, 'angiotensin': 134, 'converting': 370, 'enzyme': 554, 'inhibitor': 834, 'receptor': 1333, 'blocker': 216, 'use': 1716, 'mortality': 1035, 'personal': 1173, 'protective': 1287, 'equipment': 566, 'healthcare': 714, 'professionals': 1265, 'wuhan': 1782, 'cross': 402, 'sectional': 1451, 'role': 1414, 'directionality': 479, 'heterogeneity': 721, 'correlations': 382, 'pandemic': 1142, 'balancing': 193, 'policy': 1199, 'intervention': 862, 'icu': 759, 'sustainability': 1591, 'feasibility': 636, 'physiological': 1184, 'prone': 1276, 'positioning': 1210, 'intubated': 867, 'acute': 75, 'respiratory': 1390, 'failure': 626, 'pron': 1275, 'prospective': 1281, 'seroconversion': 1467, 'passengers': 1151, 'quarantined': 1310, 'disembarking': 485, 'cruise': 403, 'ship': 1487, 'case': 246, 'series': 1465, 'tocilizumab': 1645, 'cytokine': 410, 'release': 1366, 'hospitalized': 733, 'survival': 1586, 'genomewide': 685, 'seroprevalence': 1471, 'anti': 140, 'igg': 765, 'antibodies': 141, 'geneva': 683, 'switzerland': 1596, 'serocov': 1468, 'pop': 1207, 'population': 1208, 'age': 98, 'dependent': 438, 'epidemics': 560, 'surgical': 1582, 'complications': 328, 'italy': 885, 'rna': 1413, 'fecal': 638, 'confirmed': 340, 'effect': 525, 'large': 909, 'scale': 1433, 'contagion': 350, 'policies': 1198, 'forecasting': 666, 'local': 937, 'progression': 1271, 'medical': 995, 'emergency': 539, 'calls': 233, 'example': 588, 'paris': 1147, 'area': 161, 'face': 617, 'masks': 977, 'create': 397, 'false': 627, 'sense': 1457, 'security': 1452, 'dilemma': 475, 'characteristics': 273, 'admitted': 86, 'hospital': 729, 'uk': 1691, 'pulmonary': 1301, 'post': 1215, 'mortem': 1036, 'findings': 654, 'cases': 247, 'northern': 1095, 'centre': 262, 'descriptive': 446, 'benefit': 200, 'remdesivir': 1369, 'rhesus': 1406, 'macaques': 960, 'infected': 820, '58': 50, 'pediatric': 1161, 'temporally': 1616, 'efficacy': 529, 'chloroquine': 284, 'derivatives': 443, 'comparative': 322, 'big': 204, 'data': 415, 'world': 1780, 'pharmaceutical': 1178, 'interventions': 863, 'europe': 578, 'mathematical': 982, 'spatiotemporal': 1522, 'spreading': 1530, 'covid19': 394, 'monitoring': 1030, 'predicting': 1231, 'deconfinement': 425, 'multiscale': 1046, 'hypertension': 750, 'antihypertensive': 148, 'observational': 1107, 'group': 695, 'testing': 1620, 'strategy': 1558, 'epidemiologic': 561, 'plasma': 1189, 'therapy': 1627, 'improvement': 798, 'life': 925, 'threatening': 1629, 'randomized': 1317, 'trial': 1677, 'myocarditis': 1050, 'emerging': 540, 'following': 664, 'critically': 401, 'ill': 769, 'kawasaki': 891, 'like': 927, 'serodiagnostics': 1469, 'related': 1361, 'narrative': 1055, 'postexposure': 1217, 'deaths': 421, 'demand': 433, 'services': 1474, 'neurologic': 1078, 'manifestations': 971, 'albacovid': 108, 'registry': 1359, 'chemotherapy': 276, 'anticancer': 143, 'treatments': 1674, 'heparin': 718, 'ct': 404, 'chest': 277, '4410': 45, 'physical': 1183, 'eye': 614, 'protection': 1286, 'prevent': 1249, 'person': 1172, 'anosmia': 138, 'dysgeusia': 519, 'matched': 980, 'novel': 1097, 'ethnic': 577, 'socioeconomic': 1518, 'biobank': 206, 'undergoing': 1699, 'surgery': 1581, 'perioperative': 1169, 'international': 856, 'ccc19': 256, 'course': 389, '1000': 4, 'seir': 1454, 'living': 935, 'features': 637, '20': 24, '133': 14, 'isaric': 878, 'characterisation': 271, 'protocol': 1289, 'containment': 354, 'routine': 1418, 'venous': 1741, 'thromboembolism': 1634, 'inadequate': 801, 'hypercoagulable': 748, '10': 3, 'days': 418, 'hospitalization': 731, 'black': 214, 'white': 1772, 'chilblain': 279, 'acral': 70, 'skin': 1508, 'lesions': 919, 'really': 1329, 'indicative': 812, 'literature': 933, 'assessment': 176, 'receiving': 1332, 'thromboprophylaxis': 1636, 'incidence': 802, 'dimer': 476, 'predictive': 1234, 'stochasticity': 1552, 'correlation': 381, 'immune': 775, 'self': 1455, 'reported': 1377, 'depression': 440, 'convalescence': 365, 'scope': 1442, 'quality': 1306, 'inclusivity': 803, 'guidelines': 700, 'produced': 1263, 'rapid': 1318, 'isolate': 880, 'theoretical': 1623, 'framework': 670, 'tracing': 1657, 'interpretable': 858, 'prediction': 1232, 'rheumatic': 1407, 'brescia': 227, 'lombardy': 942, 'admission': 84, 'critical': 400, '5279': 47, 'city': 287, 'california': 232, 'washington': 1766, 'individual': 814, 'variation': 1733, 'susceptibility': 1587, 'exposure': 607, 'lowers': 952, 'herd': 720, 'threshold': 1630, 'susceptible': 1588, 'supply': 1575, 'limits': 930, 'climate': 291, 'quarantine': 1309, 'versus': 1747, 'active': 73, 'contacts': 349, 'mitigation': 1019, 'lifestyle': 926, 'mechanisms': 991, 'community': 320, '387': 40, '109': 7, 'adults': 90, 'biases': 203, 'remedies': 1370, 'reduce': 1344, 'mixing': 1020, 'reveals': 1402, 'influence': 828, 'safety': 1426, 'tolerability': 1646, 'immunogenicity': 780, 'recombinant': 1337, 'adenovirus': 80, 'type': 1688, 'vectored': 1739, 'dose': 503, 'escalation': 569, 'open': 1117, 'label': 904, 'randomised': 1316, 'macrolide': 961, 'multinational': 1044, 'internet': 857, 'search': 1446, 'investigate': 872, 'symptom': 1597, 'epidemiology': 563, 'solid': 1519, 'organ': 1124, 'transplant': 1666, 'recipients': 1334, 'initial': 837, 'epicenter': 557, 'neuroimaging': 1077, 'signal': 1495, 'thromboembolic': 1633, 'strong': 1562, 'prognostic': 1270, 'marker': 973, 'poor': 1206, 'patient': 1156, 'outcome': 1129, 'heart': 715, 'mis': 1015, 'context': 357, 'global': 688, 'arterial': 165, 'thrombosis': 1637, 'fatal': 630, 'results': 1396, 'single': 1503, 'center': 259, 'clinicopathologic': 296, 'artificial': 169, 'intelligence': 848, 'enabled': 545, 'corticosteroids': 384, 'tnf': 1644, 'antagonists': 139, 'adverse': 92, 'bowel': 223, 'diseases': 484, 'arrhythmic': 163, 'hour': 736, 'qt': 1304, 'interval': 861, 'variability': 1731, 'poisoning': 1197, 'comprehensive': 329, 'experimental': 601, 'toxicology': 1654, 'diazepam': 467, 'neurological': 1079, 'neuro': 1076, 'invasive': 870, 'modeling': 1023, 'influenza': 830, 'vaccination': 1724, 'public': 1297, 'health': 713, 'limited': 929, 'capability': 239, 'posttraumatic': 1220, 'stress': 1559, 'care': 245, 'workers': 1778, 'corona': 374, 'virus': 1753, 'reduction': 1347, 'hospitalizations': 732, 'myocardial': 1049, 'infarction': 819, 'era': 567, 'oxford': 1135, 'royal': 1420, 'college': 313, 'general': 680, 'practitioners': 1228, 'research': 1382, 'primary': 1253, 'experience': 598, 'infections': 822, 'swiss': 1595, 'nonintubated': 1093, 'hypoxemic': 755, 'tracking': 1658, 'predict': 1230, 'fibrinolysis': 646, 'shutdown': 1492, 'correlates': 380, 'events': 583, 'management': 968, 'kidney': 897, 'injury': 839, 'excess': 589, 'year': 1784, 'according': 64, 'underlying': 1700, 'conditions': 338, 'negative': 1066, 'reverse': 1403, 'transcriptase': 1661, 'polymerase': 1201, 'chain': 267, 'reaction': 1323, 'tests': 1621, 'low': 950, 'domestic': 499, 'cats': 249, 'incubation': 807, 'period': 1167, 'publicly': 1298, 'application': 155, 'italian': 884, 'epicentre': 558, 'development': 458, 'validation': 1729, 'score': 1443, 'occurrence': 1110, 'young': 1787, 'dc': 419, 'region': 1356, 'immunodeficiency': 778, '33': 38, 'prognosis': 1269, 'gastrointestinal': 678, 'liver': 934, 'involvement': 874, 'triple': 1680, 'combination': 315, 'interferon': 853, 'beta': 201, '1b': 22, 'lopinavir': 948, 'ritonavir': 1412, 'ribavirin': 1410, 'phase': 1181, 'canadian': 234, 'intensive': 849, 'units': 1708, 'longitudinal': 946, 'hematologic': 717, 'immunologic': 783, 'variations': 1734, 'abdominal': 59, 'imaging': 774, 'observations': 1108, 'hyperinflammatory': 749, 'shock': 1488, 'significance': 1497, 'prevalence': 1248, 'loss': 949, 'smell': 1511, 'taste': 1611, 'viral': 1751, 'asymptomatic': 181, 'perinatal': 1166, 'depressive': 441, 'anxiety': 153, 'prolongation': 1273, 'torsades': 1651, 'pointes': 1195, 'sudden': 1570, 'short': 1489, 'courses': 390, 'used': 1717, 'studies': 1565, 'current': 407, 'smoking': 1512, 'nicotine': 1088, 'therapeutic': 1624, 'option': 1122, 'possible': 1214, 'airborne': 105, 'diffusion': 472, 'air': 104, 'particulate': 1148, 'matter': 983, 'pm': 1193, 'comparison': 325, 'male': 966, 'female': 640, 'reason': 1330, 'different': 470, 'sex': 1481, 'mild': 1011, 'moderate': 1026, 'value': 1730, 'leukocytosis': 921, 'lymphopenia': 959, 'pregnancies': 1238, 'anticoagulation': 146, 'cardiac': 242, 'drug': 510, 'reactions': 1324, 'pharmacovigilance': 1180, 'centers': 260, 'pcr': 1160, 'london': 943, 'concurrent': 336, 'haematological': 702, 'malignancies': 967, 'hepatic': 719, 'implications': 793, 'physiology': 1185, 'chronic': 286, 'evaluation': 582, 'ii': 767, 'predictor': 1235, 'corticosteroid': 383, 'persons': 1175, 'mers': 1002, 'reduced': 1345, 'unit': 1706, 'admissions': 85, 'autopsy': 188, 'shield': 1486, 'androgen': 128, 'deprivation': 442, 'therapies': 1626, 'prostate': 1283, '4532': 46, 'lupus': 956, 'anticoagulant': 144, 'abnormal': 60, 'coagulation': 304, 'recognizing': 1336, 'proposed': 1279, 'guideline': 699, 'prevention': 1251, 'psychological': 1296, 'outbreaks': 1128, 'olfactory': 1113, 'gustatory': 701, 'dysfunction': 517, 'formalin': 667, 'fixed': 657, 'paraffin': 1145, 'embedded': 537, 'tissue': 1643, 'resection': 1383, 'tongue': 1648, 'squamous': 1532, 'cell': 257, 'carcinoma': 241, 'inhibitors': 835, 'blockers': 217, 'positive': 1211, 'high': 722, 'multicenter': 1042, 'scales': 1434, 'cutaneous': 409, 'mainly': 964, 'controlled': 360, 'deep': 429, 'learning': 915, 'fusion': 676, 'multicentre': 1043, 'contain': 352, 'evidence': 584, 'markers': 974, 'eosinopenia': 555, 'elevated': 535, 'reactive': 1326, 'protein': 1288, 'facilitate': 618, 'triage': 1676, 'fever': 644, 'clinic': 292, 'neonatal': 1067, 'late': 910, 'onset': 1115, 'mitigating': 1018, 'digital': 474, 'package': 1139, 'concomitant': 335, 'systemic': 1604, 'presenting': 1245, 'ophthalmoparesis': 1119, 'cranial': 395, 'nerve': 1071, 'palsy': 1141, 'socio': 1517, 'demographic': 434, 'problems': 1260, 'chinese': 283, 'evaluating': 581, 'serological': 1470, 'status': 1545, 'indirect': 813, 'immunofluorescent': 779, 'assay': 171, 'pre': 1229, 'existing': 593, 'united': 1707, 'states': 1543, 'epidemiological': 562, '420': 44, 'european': 579, 'transfusion': 1662, '107': 6, 'discharged': 481, 'hospitals': 734, 'renin': 1372, 'aldosterone': 110, 'cerebrospinal': 264, 'fluid': 659, 'stroke': 1561, 'departments': 437, 'second': 1448, 'trimester': 1679, 'miscarriage': 1016, 'woman': 1775, 'hypolipidemia': 752, 'confirmation': 339, 'cumulative': 406, 'thrombotic': 1638, 'updated': 1712, 'periods': 1168, 'decreased': 427, 'cardiovascular': 244, 'renal': 1371, 'fatty': 632, 'acid': 68, 'binding': 205, 'diabetes': 460, 'load': 936, 'serum': 1472, 'biomakers': 210, 'appear': 154, 'vulnerable': 1762, 'objective': 1105, 'ageusia': 102, '72': 53, 'specific': 1523, '168': 19, 'elevations': 536, 'biomarkers': 212, 'correlate': 379, 'changes': 270, 'patterns': 1158, 'shape': 1482, 'pooling': 1205, 'samples': 1428, 'fdg': 635, 'pet': 1177, 'highly': 724, 'suspicious': 1590, 'long': 944, 'term': 1617, 'coexistence': 306, 'burden': 230, 'exposed': 606, 'factor': 622, 'containing': 353, 'maternal': 981, 'interleukin': 855, 'limb': 928, 'ischemia': 879, 'understanding': 1701, 'axis': 191, '015': 1, 'hubei': 738, 'province': 1290, 'rads': 1315, 'categorical': 248, 'scheme': 1437, 'suspected': 1589, 'definition': 430, '391': 41, '1286': 13, 'close': 297, 'shenzhen': 1485, 'psychiatric': 1295, 'service': 1473, 'immunopsychiatry': 786, 'positivity': 1212, 'vascular': 1735, 'neutralizing': 1082, 'recovered': 1341, 'residents': 1384, 'homeless': 727, 'shelter': 1484, 'boston': 222, 'vaginal': 1728, 'delivery': 432, 'shortage': 1490, 'comparing': 324, 'scientific': 1440, 'methods': 1007, 'respirator': 1388, 'reuse': 1401, 'overseas': 1133, 'department': 436, 'mayotte': 984, 'modified': 1027, 'deterministic': 456, 'stochastic': 1551, 'temperature': 1614, 'humidity': 741, 'daily': 412, '166': 18, 'countries': 386, 'mortal': 1034, 'inpatient': 841, 'coagulopathy': 305, 'caucasian': 250, 'aerodynamic': 93, 'serial': 1464, 'ocular': 1111, 'tropism': 1681, 'umifenovir': 1695, 'improved': 797, 'aerosol': 94, 'filtration': 653, 'efficiency': 530, 'common': 319, 'fabrics': 616, 'cloth': 300, 'does': 496, 'invade': 869, 'brain': 224, 'translational': 1663, 'lessons': 920, 'animal': 135, 'models': 1025, 'month': 1032, 'integrated': 846, 'fibrinolytic': 647, 'abnormalities': 61, 'distress': 493, 'versatility': 1746, 'thrombolytic': 1635, 'drugs': 511, 'treat': 1670, 'african': 97, 'controls': 362, 'south': 1520, 'africa': 96, 'egypt': 532, 'algeria': 111, 'nigeria': 1090, 'senegal': 1456, 'kenyascien': 892, 'eculizumab': 524, 'asl': 170, 'napoli': 1054, 'nord': 1094, 'procalcitonin': 1262, 'infant': 817, 'direct': 478, 'oral': 1123, 'levels': 922, 'striking': 1560, 'increase': 805, 'antiviral': 151, 'agents': 100, 'cremona': 398, 'online': 1114, 'information': 831, 'isolation': 881, 'intention': 851, 'presymptomatic': 1247, 'skilled': 1507, 'nursing': 1103, 'facility': 621, 'imported': 795, 'embolism': 538, 'angiography': 133, 'relationship': 1363, 'exogenous': 595, 'estrogen': 575, 'decontamination': 426, 'steam': 1547, 'mask': 976, 'fighting': 650, 'supports': 1578, 'med': 992, 'characteristic': 272, 'distinguishing': 492, 'vs': 1761, 'doses': 504, 'diphosphate': 477, 'adjunctive': 81, 'unexpected': 1704, 'pressure': 1246, 'septic': 1461, 'neutralization': 1081, 'spike': 1528, 'pseudotyped': 1293, 'ace2': 67, 'ig': 764, 'entry': 552, 'expressed': 608, 'nasal': 1056, 'epithelial': 564, 'cells': 258, 'innate': 840, 'genes': 682, 'assays': 172, 'associations': 180, 'netherlands': 1074, 'wide': 1773, 'wearing': 1769, 'auxiliary': 189, 'diagnostic': 464, 'extracorporeal': 610, 'membrane': 998, 'oxygenation': 1137, 'compromise': 330, '32': 37, 'disorders': 487, 'pilot': 1186, '116': 10, 'anticoagulated': 145, 'sévère': 1606, 'parameters': 1146, 'assess': 173, 'comorbidities': 321, '5700': 49, 'description': 445, 'specificity': 1524, 'analyses': 125, 'ambient': 119, 'size': 1505, 'iran': 877, 'cluster': 302, 'closed': 298, '121': 12, 'usage': 1715, 'veterans': 1749, 'connecting': 343, 'clusters': 303, 'investigation': 873, 'cause': 251, 'ketosis': 895, 'ketoacidosis': 894, 'hypercoagulability': 747, 'guidance': 698, 'antivirals': 152, 'staffs': 1537, 'adjustment': 83, 'compared': 323, 'curtail': 408, 'performance': 1165, 'clinically': 294, 'nicotinic': 1089, 'hypothesis': 754, 'preventive': 1252, 'peripheral': 1170, 'lymphocyte': 958, 'subsets': 1567, 'cytokines': 411, 'candidate': 236, 'middle': 1010, 'east': 521, 'uncontrolled': 1698, 'zhejiang': 1789, 'cerebrovascular': 265, 'increased': 806, 'pooled': 1204, 'published': 1299, 'scoring': 1444, 'systems': 1605, 'pregnancy': 1239, 'arbidol': 158, 'combined': 316, 'lpv': 953, 'antithrombotic': 150, 'follow': 662, 'vaccinia': 1727, 'ankara': 137, 'vector': 1738, 'sepsis': 1460, 'hypotheses': 753, 'dynamic': 515, 'arteriosclerosis': 166, 'obliterans': 1106, 'lower': 951, 'extremities': 611, 'older': 1112, 'geriatric': 687, 'stay': 1546, 'dedicated': 428, 'length': 917, 'exploratory': 603, 'manifestation': 970, 'successful': 1569, 'induced': 816, 'refractory': 1352, 'cardiogenic': 243, 'plus': 1192, 'vasoplegic': 1737, 'pvad': 1303, 'ecmo': 522, 'miller': 1013, 'fisher': 655, 'polyneuritis': 1202, 'cranialis': 396, 'signals': 1496, 'profiles': 1267, 'swabs': 1594, '353': 39, 'received': 1331, 'simultaneously': 1501, 'wards': 1764, 'hygiene': 745, 'secretions': 1450, 'prolonged': 1274, 'untreated': 1711, 'wastewater': 1767, 'australia': 185, 'proof': 1277, 'concept': 332, 'mainland': 963, 'suppressed': 1579, 'mediated': 994, 'laboratory': 907, '2510': 33, 'temporal': 1615, 'lung': 954, 'tool': 1649, 'nomogram': 1091, 'guangdong': 696, 'decline': 424, 'coronary': 375, 'austria': 186, 'causes': 253, 'collateral': 311, 'damage': 413, 'relative': 1365, 'count': 385, 'flow': 658, 'cannula': 238, 'good': 693, 'mental': 1000, 'sequential': 1463, 'neonate': 1068, 'mother': 1037, 'relationships': 1364, 'inflammation': 825, 'ile': 768, 'nationwide': 1059, 'worsening': 1781, 'glycosylated': 691, 'haemoglobin': 705, 'simulation': 1500, 'multivariate': 1048, 'regression': 1360, 'central': 261, 'nervous': 1072, 'exchange': 590, 'followed': 663, 'intravenous': 864, 'immunogloblin': 781, 'media': 993, 'amiodarone': 122, '062': 2, 'copd': 371, 'history': 725, 'nt': 1100, 'probnp': 1261, 'preventing': 1250, 'infectious': 823, 'contaminated': 355, 'fluids': 660, 'staff': 1536, 'imperfect': 791, 'storm': 1555, 'durable': 512, 'lvad': 957, 'support': 1576, 'icelandic': 758, 'keratoconjunctivitis': 893, 'estimates': 572, 'numbers': 1102, 'optimizing': 1121, 'dosing': 505, 'integrative': 847, 'repurposing': 1379, 'biochemical': 207, 'biomarker': 211, 'airway': 106, 'consensus': 345, 'society': 1516, 'anesthesia': 129, 'difficult': 471, 'collaborative': 310, 'neonates': 1069, 'born': 221, 'mothers': 1038, 'digestive': 473, 'anal': 124, 'inactivation': 800, 'recommended': 1340, 'hand': 707, 'rub': 1422, 'formulations': 669, 'alcohols': 109, 'hypertensive': 751, 'controversies': 364, 'pathogenesis': 1153, 'neuropsychiatric': 1080, 'faers': 625, 'database': 416, 'classification': 289, 'fetuses': 643, 'immunological': 784, 'available': 190, 'commercial': 317, 'measure': 985, 'antigen': 147, 'pollution': 1200, 'glucocorticoids': 690, 'familial': 628, 'protecting': 1285, 'labor': 906, 'personnel': 1174, 'stage': 1538, 'controlling': 361, 'rolling': 1415, '120': 11, 'consecutive': 344, 'workforce': 1779, 'environmental': 553, 'oxygen': 1136, 'requirement': 1380, 'routinely': 1419, 'collected': 312, 'emulate': 543, 'target': 1608, 'vitro': 1757, 'activity': 74, 'doxycycline': 507, 'neutrophil': 1083, 'ratio': 1320, 'independent': 808, 'immunochromatographic': 777, 'tracheostomy': 1656, 'monotherapy': 1031, 'superior': 1572, 'treating': 1672, 'statins': 1544, 'estimated': 571, 'total': 1652, 'projected': 1272, 'plausibility': 1191, 'rho': 1409, 'kinase': 898, 'demonstrating': 435, 'youngsters': 1788, '16': 17, 'years': 1785, 'scenarios': 1436, 'lock': 940, 'assessing': 175, 'uncertainty': 1697, 'predictions': 1233, 'exploring': 604, 'thrombocytopenia': 1632, 'unanswered': 1696, 'disinfection': 486, 'n95': 1051, 'respirators': 1389, 'ionized': 876, 'hydrogen': 743, 'peroxide': 1171, 'xpert': 1783, 'ai': 103, 'powered': 1223, 'radiography': 1313, 'images': 773, 'alps': 117, 'tract': 1659, 'toronto': 1650, 'ontario': 1116, '1061': 5, 'predictors': 1236, 'caused': 252, 'hospitalised': 730, 'immunotherapy': 788, 'members': 997, 'assisted': 177, 'seattle': 1447, 'seven': 1478, 'primer': 1255, 'probe': 1259, 'sets': 1475, 'kit': 901, 'compassionate': 326, 'replication': 1375, 'activation': 72, 'lungs': 955, 'ex': 585, 'vivo': 1759, 'throat': 1631, 'washings': 1765, 'timing': 1642, 'initiation': 838, 'obesity': 1104, 'requiring': 1381, 'mechanical': 988, 'ventilation': 1743, 'trials': 1678, 'tumour': 1684, 'necrosis': 1062, 'urgently': 1713, 'needed': 1064, 'family': 629, 'diagnosed': 462, '14': 15, 'day': 417, 'ferrets': 642, 'dogs': 497, 'domesticated': 500, 'animals': 136, 'wave': 1768, 'transmissibility': 1664, 'scenario': 1435, 'planning': 1188, 'illnesses': 771, 'synchronous': 1599, 'vaso': 1736, 'occlusive': 1109, 'crisis': 399, 'sickle': 1494, 'antiphospholipid': 149, 'madrid': 962, 'spain': 1521, 'resource': 1386, 'allocation': 115, 'resuscitation': 1398, 'postresuscitation': 1219, 'infants': 818, 'practice': 1227, 'method': 1006, 'bedside': 198, 'postpyloric': 1218, 'tube': 1683, 'placement': 1187, 'interactions': 852, 'qtc': 1305, 'atazanavir': 182, 'inhibits': 836, 'pro': 1258, 'production': 1264, 'locally': 938, 'informed': 832, 'capacity': 240, 'needs': 1065, 'challenges': 269, 'recommendations': 1339, 'detected': 450, 'thoracic': 1628, 'significant': 1498, 'accurate': 65, 'exacerbation': 586, 'psoriasis': 1294, 'oseltamivir': 1126, 'immunoglobulin': 782, 'deteriorating': 452, 'contagiousness': 351, 'dysfunctions': 518, 'forms': 668, 'nosocomial': 1096, 'ward': 1763, 'setting': 1476, 'hong': 728, 'kong': 903, 'effectiveness': 527, 'transplantation': 1667, 'mesenchymal': 1003, 'stem': 1548, 'improves': 799, 'surrounding': 1583, 'regions': 1358, 'vitamin': 1756, 'supplementation': 1574, 'generalized': 681, 'pustular': 1302, 'figurate': 652, 'erythema': 568, 'newly': 1087, 'delineated': 431, 'linked': 931, 'focus': 661, 'congenital': 341, 'troponin': 1682, 'ally': 116, 'fight': 649, 'harmful': 709, 'discontinuing': 482, 'ace': 66, 'arbs': 159, 'school': 1438, 'closures': 299, 'net': 1073, 'variance': 1732, 'referred': 1350, 'structural': 1563, 'acc': 63, 'scai': 1432, 'statement': 1542, 'fibrosis': 648, 'baseline': 196, '1591': 16, 'icus': 760, 'causing': 254, 'difference': 468, 'cov2': 392, 'ncov': 1061, 'home': 726, 'interim': 854, 'puerperium': 1300, 'figo': 651, 'allied': 113, 'partners': 1149, 'blockchain': 215, 'technology': 1612, 'favipiravir': 633, 'pharmacokinetics': 1179, 'concerns': 334, 'paediatric': 1140, 'provisional': 1292, 'ibd': 756, 'porto': 1209, 'espghan': 570, 'exhaled': 592, 'breath': 226, 'donations': 501, 'fda': 634, 'approved': 157, 'ivermectin': 886, 'meteorological': 1005, 'meningitis': 999, 'encephalitis': 547, 'barrier': 194, 'enclosure': 548, 'endotracheal': 551, '85': 57, 'breastfeeding': 225, 'ad': 76, 'indications': 811, 'neonatology': 1070, 'endorsed': 550, 'union': 1705, 'societies': 1515, 'siltuximab': 1499, 'ventilatory': 1745, 'surface': 1580, 'contamination': 356, 'rooms': 1417, 'molecular': 1028, 'weight': 1771, 'relieving': 1368, 'exported': 605, 'country': 387, 'impairment': 790, '115': 9, 'elderly': 534, 'week': 1770, 'detectable': 449, 'genome': 684, 'ultrasound': 1693, 'identification': 761, 'grading': 694, 'conditioning': 337, 'restaurant': 1393, 'guangzhou': 697, 'coronaviruses': 377, 'utilities': 1719, 'instant': 845, 'chongqing': 285, '273': 35, 'expression': 609, 'indicates': 810, 'mechanism': 990, 'headaches': 712, 'frontline': 674, 'happe': 708, 'vivadiagtm': 1758, 'igm': 766, 'referring': 1351, 'room': 1416, 'result': 1395, 'stability': 1534, 'issues': 883, 'contributes': 358, 'alleviate': 112, 'improve': 796, 'absence': 62, 'ppe': 1224, 'tilorone': 1640, 'broad': 228, 'spectrum': 1527, 'invented': 871, 'usa': 1714, 'commercialized': 318, 'russia': 1423, 'mobility': 1021, 'mitigate': 1017, 'singapore': 1502, 'coincidence': 309, 'universal': 1709, 'bcg': 197, 'morbidity': 1033, 'expanded': 596, 'umbilical': 1694, 'cord': 372, 'uc': 1690, 'mscs': 1040, 'managing': 969, 'king': 900, 'county': 388, 'step': 1549, 'loop': 947, 'isothermal': 882, 'amplification': 123, 'lamp': 908, 'potentially': 1222, 'reliable': 1367, 'throughput': 1639, 'distribution': 494, 'radiographic': 1312, 'quantifying': 1307, 'gautret': 679, 'et': 576, 'al': 107, 'resolution': 1385, 'computed': 331, 'tomography': 1647, 'ages': 101, 'uv': 1722, 'sterilization': 1550, 'idle': 763, 'biosafety': 213, 'cabinets': 231, 'diagnostics': 465, 'therapeutics': 1625, 'controversial': 363, 'article': 168, 'possibility': 1213, 'faecal': 624, 'genomic': 686, 'phylogenetic': 1182, '68': 51, 'assessed': 174, 'regional': 1357, '54': 48, 'immunologists': 785, '113': 8, 'deceased': 422, 'training': 1660, 'fit': 656, 'reusable': 1400, 'elastomeric': 533, 'half': 706, 'disposable': 488, 'vertical': 1748, 'sras': 1533, 'newborn': 1085, 'microbiological': 1009, '80': 56, 'determined': 455, 'culture': 405, 'discharge': 480, 'turbulent': 1685, 'gas': 677, 'clouds': 301, 'pathogen': 1152, 'emissions': 541, 'reducing': 1346, 'adjusted': 82, 'diamond': 466, 'princess': 1256, 'shows': 1491, 'synergistic': 1601, 'challenge': 268, 'rheumatologists': 1408, 'convert': 369, 'classic': 288, 'lianhuaqingwen': 923, 'exerts': 591, 'th17': 1622, 'jak2': 887, 'fedratinib': 639, 'hcv': 711, 'protease': 1284, 'danoprevir': 414, 'naive': 1052, 'experienced': 599, 'meplazumab': 1001, 'treats': 1675, 'labelled': 905, 'add': 78, 'ambulatory': 120, 'referral': 1349, '31st': 36, '1st': 23, 'snapshot': 1513, 'identifying': 762, 'locations': 939, 'undetected': 1702, 'importation': 794, 'perspective': 1176, 'perform': 1164, 'fibreoptic': 645, 'tracheal': 1655, 'insights': 844, 'nanomedicine': 1053, 'ultrasonography': 1692, 'novelcorona': 1098, '2020epidemic': 28, 'domain': 498, 'rbd': 1322, 'implication': 792, 'attachment': 184, 'kinetics': 899, 'clearance': 290, 'recruitability': 1343, 'milder': 1012, 'better': 202, 'hypercapnic': 746, 'mechanically': 989, 'ventilated': 1742, 'rational': 1321, 'harms': 710, 'exaggerated': 587, 'turned': 1687, 'arouses': 162, 'concern': 333, 'regarding': 1353, 'present': 1243, 'standard': 1539, 'presence': 1242, 'newborns': 1086, 'utilizing': 1721, 'biologics': 209, 'interrupted': 859, 'par': 1143, 'le': 914, 'chez': 278, 'les': 918, 'femmes': 641, 'enceintes': 546, 'état': 1790, 'des': 444, 'connaissances': 342, 'proposition': 1280, 'prise': 1257, 'en': 544, 'charge': 275, 'resources': 1387, 'economic': 523, 'dying': 514, 'relation': 1362, 'toughest': 1653, 'allocating': 114, 'ventilators': 1744, 'emotional': 542, 'profiling': 1268, 'humoral': 742, 'diagnose': 461, 'rhabdomyolysis': 1405, 'complication': 327, 'added': 79, '73': 54, 'art': 164, 'endoribonuclease': 549, 'targets': 1609, 'polyuridine': 1203, 'sequences': 1462, 'evade': 580, 'activating': 71, 'host': 735, 'sensors': 1459, 'terminal': 1618, 'recommendation': 1338, 'joint': 890, 'task': 1610, 'force': 665, 'anesthesiology': 130, 'supporting': 1577, 'clinicians': 295, 'haemodialysis': 704, 'centres': 263, 'expert': 602, 'blocking': 218, 'drive': 508, 'safe': 1424, 'efficient': 531, 'massive': 979, 'withdrawn': 1774, '3c': 42, '3clpro': 43, 'virtual': 1752, 'velpatasvir': 1740, 'ledipasvir': 916, 'candidates': 237, 'slow': 1509, 'exuberant': 613, 'plasmacytosis': 1190, 'bronchoalveolar': 229, 'lavage': 911, 'anesthetists': 132, 'intensivists': 850, 'know': 902, 'amid': 121, 'doubt': 506, 'multiple': 1045, 'introduction': 865, 'overview': 1134, 'stop': 1554, 'biologic': 208, 'natural': 1060, 'small': 1510, 'molecules': 1029, 'lipid': 932, 'reference': 1348, 'seriousness': 1466, 'distinguishes': 491, 'acquired': 69, 'paucisymptomatic': 1159, 'settings': 1477, '21': 29, 'inwashington': 875, 'radiologic': 1314, 'interrupting': 860, 'superspreading': 1573, 'advances': 91, 'prospects': 1282, 'developing': 457, 'vaccines': 1726, 'immunotherapeutics': 787, 'insight': 843, 'pediatricians': 1162, 'corner': 373, 'stable': 1535, 'artery': 167, 'ldl': 913, 'inflammatories': 826, 'travelers': 1669, 'need': 1063, 'longer': 945, 'starts': 1540, 'points': 1196, '260': 34, '000': 0, 'heilongjiang': 716, 'utility': 1720, 'determinations': 454, 'recognition': 1335, 'jiangsu': 889, '919': 58, 'adamantanes': 77, 'ibuprofen': 757, 'say': 1431, 'doctors': 495, 'scientists': 1441, 'lidocaine': 924, 'extubation': 612, 'pathogenic': 1154, 'fulminant': 675, 'saved': 1430, 'glucocorticoid': 689, 'substantial': 1568, 'undocumented': 1703, 'facilitates': 619, 'dissemination': 489, 'predisposition': 1237, 'npis': 1099, '2143': 30, 'adoption': 88, 'income': 804, 'affect': 95, 'eyes': 615, 'humans': 740, 'image': 772, 'visual': 1755, 'quantitative': 1308, 'haematology': 703, 'considercytokine': 347, 'stormsyndromes': 1556, 'andimmunosuppression': 127, 'facilities': 620, 'highest': 723, 'teicoplanin': 1613, 'alternative': 118, 'word': 1777, 'caution': 255, 'si': 1493, 'vis': 1754, 'pacem': 1138, 'para': 1144, 'bellum': 199, 'systematicreview': 1603, 'sustained': 1592, 'regimen': 1354, 'eosinophil': 556, 'readily': 1327, 'convalescentcovid': 367, 'mellitus': 996, 'atincreased': 183, 'cohortstudy': 308, 'reactivation': 1325, 'typesof': 1689, 'influences': 829, 'decision': 423, 'makers': 965, 'authorities': 187, 'anesthetic': 131, 'parturients': 1150, 'cesarean': 266, 'stool': 1553, 'specimen': 1525, 'child': 280, 'travel': 1668, 'restrictions': 1394, '2019novel': 26, 'practicalconsiderations': 1226, 'recovery': 1342}\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"x9oQyaUovOst"},"source":["bag_of_words = vect.transform(texts)\n","bag_of_words2 = vect2.transform(texts)\n"],"execution_count":null,"outputs":[]},{"cell_type":"markdown","metadata":{"id":"wtME9exvvOst"},"source":["### Séparation test / train"]},{"cell_type":"markdown","metadata":{"id":"YMoTa42yoIYD"},"source":["Nous allons séparer les données en données d'entrainement et de test. Nous utiliserons que la représentation Tfid car avec la représentation CountVectorizer, ce n'est pas bon du tout (voir dans rapport)."]},{"cell_type":"code","metadata":{"id":"6myI2yR7vOst"},"source":["from sklearn.model_selection import train_test_split\n","\n","X_train, X_test, y_train, y_test = train_test_split(bag_of_words2, Y, test_size=0.2)\n","X_train2, X_test2, y_train2, y_test2 = train_test_split(bag_of_words, Y, test_size=0.2)"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"OmOYZS8YvOsu","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609583478249,"user_tz":-60,"elapsed":858,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"552ec1c0-0610-4f68-e2f8-1c150824a3bf"},"source":["print(X_train.shape, y_train.shape)\n","print(X_test.shape, y_test.shape)"],"execution_count":null,"outputs":[{"output_type":"stream","text":["(545, 1792) (545, 19)\n","(137, 1792) (137, 19)\n"],"name":"stdout"}]},{"cell_type":"markdown","metadata":{"id":"XL3xKjoQvOsu"},"source":["## KNN\n","On va d'abord tester avec les modèles sk-learn qui nous permettent de traiter les problèmes multi-label. Ci-dessous les modèles sont entrainés seulement avec les titres des articles avec une représentation TFid. Nous avons tester aussi avec les abstract et/ ou la représentation CountVectorizer mais c'était moins bon (voir résultats dans rapport)."]},{"cell_type":"code","metadata":{"id":"NGOvGnDUvOsu"},"source":["from sklearn.neighbors import KNeighborsClassifier\n","from sklearn.model_selection import GridSearchCV\n","from sklearn.metrics import multilabel_confusion_matrix"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"2Q0uF7l9vOsu","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609583485815,"user_tz":-60,"elapsed":6089,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"3e122e93-f833-45ec-f82b-679215916285"},"source":["k_range = list(range(1,15))\n","weight_options = [\"uniform\", \"distance\"]\n","\n","param_grid = dict(n_neighbors = k_range, weights = weight_options)\n","knn = KNeighborsClassifier()\n","\n","grid = GridSearchCV(knn, param_grid, cv = 3, scoring = 'f1_micro')\n","grid.fit(X_train,y_train)\n","\n","print (grid.best_score_)\n","print (grid.best_params_)\n","print (grid.best_estimator_)"],"execution_count":null,"outputs":[{"output_type":"stream","text":["0.4530529128535257\n","{'n_neighbors': 4, 'weights': 'distance'}\n","KNeighborsClassifier(algorithm='auto', leaf_size=30, metric='minkowski',\n","                     metric_params=None, n_jobs=None, n_neighbors=4, p=2,\n","                     weights='distance')\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"4Cu_51jYvOsv","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609583485818,"user_tz":-60,"elapsed":4261,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"280934de-3b0e-45d6-ed34-e9d81c9e98cc"},"source":["from sklearn.metrics import f1_score\n","import pandas as pd\n","\n","best_knn = grid.best_estimator_\n","y_pred = best_knn.predict(X_test)\n","score = f1_score(y_test,y_pred , average='micro',zero_division=0)\n","score"],"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["0.47230320699708456"]},"metadata":{"tags":[]},"execution_count":129}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"srxgW3tvSPk-","executionInfo":{"status":"ok","timestamp":1609583485820,"user_tz":-60,"elapsed":2835,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"894ed686-4cd1-4660-c4f4-295e8cd962e3"},"source":["KNN = {'f1-micro':score, 'f1-macro':f1_score(y_test,y_pred , average='macro',zero_division=0),'f1-weighted': f1_score(y_test,y_pred , average='weighted',zero_division=0),'f1-samples':f1_score(y_test,y_pred , average='samples',zero_division=0)}\n","KNN"],"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["{'f1-macro': 0.3651784324114907,\n"," 'f1-micro': 0.47230320699708456,\n"," 'f1-samples': 0.4233576642335766,\n"," 'f1-weighted': 0.460829595665916}"]},"metadata":{"tags":[]},"execution_count":130}]},{"cell_type":"markdown","metadata":{"id":"kZ9oIs5MvOsv"},"source":["## Random Forest"]},{"cell_type":"code","metadata":{"id":"4Jyj5WvYvOsv"},"source":["from sklearn.ensemble import RandomForestClassifier"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"q86XkpOtvOsw","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609583487293,"user_tz":-60,"elapsed":1987,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"3c7c5f48-2984-4487-e065-985894f6be10"},"source":["forest = RandomForestClassifier()\n","forest.fit(X_train,y_train)"],"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["RandomForestClassifier(bootstrap=True, ccp_alpha=0.0, class_weight=None,\n","                       criterion='gini', max_depth=None, max_features='auto',\n","                       max_leaf_nodes=None, max_samples=None,\n","                       min_impurity_decrease=0.0, min_impurity_split=None,\n","                       min_samples_leaf=1, min_samples_split=2,\n","                       min_weight_fraction_leaf=0.0, n_estimators=100,\n","                       n_jobs=None, oob_score=False, random_state=None,\n","                       verbose=0, warm_start=False)"]},"metadata":{"tags":[]},"execution_count":132}]},{"cell_type":"code","metadata":{"id":"kngSFJcwvOsw"},"source":["y_pred = forest.predict(X_test)\n","score = f1_score(y_test,y_pred , average='samples',zero_division=0)"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"PjwjAB0JVYhA","executionInfo":{"status":"ok","timestamp":1609583488394,"user_tz":-60,"elapsed":726,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"37afab34-b623-49ad-9238-d3b13cc030cb"},"source":["RandomForest= {'f1-micro':score, 'f1-macro':f1_score(y_test,y_pred , average='macro',zero_division=0),'f1-weighted': f1_score(y_test,y_pred , average='weighted',zero_division=0),'f1-samples':f1_score(y_test,y_pred , average='samples',zero_division=0)}\n","RandomForest"],"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["{'f1-macro': 0.17046623714922368,\n"," 'f1-micro': 0.4153284671532846,\n"," 'f1-samples': 0.4153284671532846,\n"," 'f1-weighted': 0.34355182231069625}"]},"metadata":{"tags":[]},"execution_count":134}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":112},"id":"Pk2mdesOVqMU","executionInfo":{"status":"ok","timestamp":1609583541369,"user_tz":-60,"elapsed":1237,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"908679ff-d8ac-428b-ea9d-627edbec4ccb"},"source":["scores_tfid = pd.DataFrame(index=['KNN', 'Random Forest'], columns=['f1-micro', 'f1-macro','f1-weighted','f1-samples'])\n","scores_tfid.loc['KNN'] = pd.Series(KNN)\n","scores_tfid.loc['Random Forest'] = pd.Series(RandomForest)\n","scores_tfid"],"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>f1-micro</th>\n","      <th>f1-macro</th>\n","      <th>f1-weighted</th>\n","      <th>f1-samples</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>KNN</th>\n","      <td>0.472303</td>\n","      <td>0.365178</td>\n","      <td>0.46083</td>\n","      <td>0.423358</td>\n","    </tr>\n","    <tr>\n","      <th>Random Forest</th>\n","      <td>0.415328</td>\n","      <td>0.170466</td>\n","      <td>0.343552</td>\n","      <td>0.415328</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>"],"text/plain":["               f1-micro  f1-macro f1-weighted f1-samples\n","KNN            0.472303  0.365178     0.46083   0.423358\n","Random Forest  0.415328  0.170466    0.343552   0.415328"]},"metadata":{"tags":[]},"execution_count":137}]},{"cell_type":"markdown","metadata":{"id":"6f7nMDJYvOsw"},"source":["## Prédictions des classes une par une : stratégie one vs rest\n","\n","On fait une régréssion logistique binaire pour tous les labels pour prédire si oui ou non on aura ce label pour ce texte. (inspiré de https://towardsdatascience.com/journey-to-the-center-of-multi-label-classification-384c40229bff)\n","\n","On suppose donc ici qu'il n'y a pas de corrélation entre les labels."]},{"cell_type":"code","metadata":{"id":"GSoyD3zcvOsw"},"source":["from sklearn.linear_model import LogisticRegression\n","from sklearn.svm import LinearSVC\n","from sklearn.naive_bayes import MultinomialNB\n","from sklearn.pipeline import Pipeline\n","from sklearn.metrics import accuracy_score\n","from sklearn.multiclass import OneVsRestClassifier\n","\n","LogReg_pipeline = Pipeline([\n","                ('clf', OneVsRestClassifier(LogisticRegression(solver='sag'))),\n","            ])"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"0BAI7E7hvOsw","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1609579461947,"user_tz":-60,"elapsed":1046,"user":{"displayName":"Juliette Philibert","photoUrl":"https://lh3.googleusercontent.com/a-/AOh14GgX2TQ1Ane3pvNgIl4uPXkfpl50qy7hJtkTQpgRjA=s64","userId":"09028280464559335776"}},"outputId":"ec0239ed-3af6-40ea-8c0e-fe6b53010749"},"source":["for label in range(len(LABELS)):\n","    print('**Label {} **'.format(LABELS[label]))\n","    \n","    # Training logistic regression model on train data\n","    LogReg_pipeline.fit(X_train, y_train[:,label])\n","    print(\"Entrainé avec \",np.shape(np.where(y_train[:,label]==1))[1],\"exemples avec ce label\")\n","    # calculating test accuracy\n","    prediction = LogReg_pipeline.predict(X_test)\n","    print('Accuracy: {}'.format(accuracy_score(y_test[:,label], prediction)))\n","    print(\"Testé sur \",np.shape(np.where(y_test[:,label]==1))[1],\"exemples\")\n","    print(\"\\n\")"],"execution_count":null,"outputs":[{"output_type":"stream","text":["**Label Anesthésie-Réanimation **\n","Entrainé avec  72 exemples avec ce label\n","Accuracy: 0.8467153284671532\n","Testé sur  21 exemples\n","\n","\n","**Label Infectiologie **\n","Entrainé avec  159 exemples avec ce label\n","Accuracy: 0.6204379562043796\n","Testé sur  54 exemples\n","\n","\n","**Label Transversale **\n","Entrainé avec  239 exemples avec ce label\n","Accuracy: 0.6715328467153284\n","Testé sur  48 exemples\n","\n","\n","**Label Immunité **\n","Entrainé avec  15 exemples avec ce label\n","Accuracy: 0.9708029197080292\n","Testé sur  4 exemples\n","\n","\n","**Label Virologie **\n","Entrainé avec  48 exemples avec ce label\n","Accuracy: 0.8321167883211679\n","Testé sur  23 exemples\n","\n","\n","**Label Confinement/Déconfinement **\n","Entrainé avec  15 exemples avec ce label\n","Accuracy: 0.9708029197080292\n","Testé sur  4 exemples\n","\n","\n","**Label Pédiatrie **\n","Entrainé avec  28 exemples avec ce label\n","Accuracy: 0.9051094890510949\n","Testé sur  13 exemples\n","\n","\n","**Label Pneumologie **\n","Entrainé avec  44 exemples avec ce label\n","Accuracy: 0.9051094890510949\n","Testé sur  13 exemples\n","\n","\n","**Label Gynécologie Obstétrique **\n","Entrainé avec  19 exemples avec ce label\n","Accuracy: 0.9781021897810219\n","Testé sur  3 exemples\n","\n","\n","**Label Gériatrie **\n","Entrainé avec  3 exemples avec ce label\n","Accuracy: 0.9854014598540146\n","Testé sur  2 exemples\n","\n","\n","**Label Cardiologie et maladies métaboliques **\n","Entrainé avec  48 exemples avec ce label\n","Accuracy: 0.8978102189781022\n","Testé sur  14 exemples\n","\n","\n","**Label Hygiène **\n","Entrainé avec  31 exemples avec ce label\n","Accuracy: 0.927007299270073\n","Testé sur  10 exemples\n","\n","\n","**Label Hépato-gastro-entérologie **\n","Entrainé avec  12 exemples avec ce label\n","Accuracy: 0.9927007299270073\n","Testé sur  1 exemples\n","\n","\n","**Label Neurologie **\n","Entrainé avec  15 exemples avec ce label\n","Accuracy: 0.9708029197080292\n","Testé sur  4 exemples\n","\n","\n","**Label Radiologie **\n","Entrainé avec  26 exemples avec ce label\n","Accuracy: 0.9562043795620438\n","Testé sur  6 exemples\n","\n","\n","**Label Dermatologie **\n","Entrainé avec  3 exemples avec ce label\n","Accuracy: 0.9927007299270073\n","Testé sur  1 exemples\n","\n","\n","**Label Hématologie **\n","Entrainé avec  6 exemples avec ce label\n","Accuracy: 0.9927007299270073\n","Testé sur  1 exemples\n","\n","\n","**Label Psychiatrie **\n","Entrainé avec  18 exemples avec ce label\n","Accuracy: 0.9854014598540146\n","Testé sur  2 exemples\n","\n","\n","**Label Néphrologie **\n","Entrainé avec  4 exemples avec ce label\n","Accuracy: 0.9927007299270073\n","Testé sur  1 exemples\n","\n","\n"],"name":"stdout"}]},{"cell_type":"markdown","metadata":{"id":"VpOr2Ns7vOsx"},"source":["Nous obtenons donc 19 classifieurs (1 pour chaque spécialité) expert sur sa spécialité, mais finalement ça ne parait pas pertinent car il y a des spécialités où il y a trop peu de données, le classifieur ne peut pas apprendre grand chose de cette manière. Nous n'irons donc pas plus loin pour cette approche.\n","\n","## Conclusion\n","\n","Les classifieurs \"classiques\" multilabels ne nous permettent pas d'avoir de bons résultats au vu du manque de certaines données. Nous allons maintenant tester et nous concentrer sur des méthodes deep, comme par exemple le modèle BioBert déjà pré-entrainé sur des données médicales qui permet (il parait), de bons résultats même avec très peu de données."]}]}